Zelira Therapeutics Ltd. announced that as part of a strategic consolidation of Zeliras operations, leadership will transfer to the United States based team and, Dr. Oludare Odumosu, will now assume the role of global Managing Director of Zelira. Dr. Richard Hopkins has decided to step-down as Chief Executive Officer and Managing Director ex-USA effective 15 May 2021. Dr. Hopkins will continue in his role while assisting and supporting the Company through the transition period.